CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CollPlant Biotechnologies Ltd. - Ordinary Shares (NQ:CLGN)

0.6110 -0.0101 (-1.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CollPlant Biotechnologies Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
News headline image
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention ↗
The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to... 
Via Stocktwits
Topics Artificial Intelligence Workforce
News headline image
CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Plummets 10.7% on Q3 Earnings and Revenue Miss ↗
CollPlant stock plunges 10.7% after Q3 2025 earnings miss, with revenue of $80k far below the $4.94 million estimate. 
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
What's Next: CollPlant Biotechnologies's Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Preview: CollPlant Biotechnologies ↗
 
Via Benzinga
CollPlant Biotechnologies's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies ↗
 
Via Benzinga
News headline image
Analyst Expectations For CollPlant Biotechnologies's Future ↗
 
Via Benzinga
News headline image
CollPlant Biotechnologies Ltd (NASDAQ:CLGN) Q2 2025 Earnings Fall Significantly Short of Estimates ↗
CollPlant (CLGN) Q2 2025 results miss analyst estimates, with revenue of $180K far below expectations. Shares fell in pre-market trading on the earnings disappointment. 
Via Chartmill
News headline image
Earnings Scheduled For August 20, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Recap: CollPlant Biotechnologies Q3 Earnings ↗
 
Via Benzinga
News headline image
Dow Edges Higher; Dell Shares Fall After Q1 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Down 100 Points; Chicago PMI Dips In May ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 28, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 26, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 27, 2024 ↗
 
Via Benzinga
News headline image
CLGN Stock Earnings: CollPlant Biotechnologies Beats EPS, Misses Revenue for Q2 2024 ↗
CLGN stock results show that CollPlant Biotechnologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
CLGN Stock Earnings: CollPlant Biotechnologies Meets EPS, Misses Revenue for Q1 2024 ↗
CLGN stock results show that CollPlant Biotechnologies met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
CLGN Stock Earnings: CollPlant Biotechnologies Misses EPS, Misses Revenue for Q4 2023 ↗
CLGN stock results show that CollPlant Biotechnologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For April 4, 2024 ↗
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. 
Via Benzinga
News headline image
Earnings Scheduled For November 29, 2023 ↗
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article